As befits a maker of toilet tissue, Kimberly-Clark’s chief executive Mike Hsu has come up with a deal that stacks up on paper. But investors fear that his proposed acquisition of paracetamol-and-mouthwash producer Kenvue could flush value down the pipes.
金佰利公司(Kimberly-Clark)首席执行官徐定国(Mike Hsu)拿出了一桩纸面上看起来诚意满满的交易。但投资者担心，他对对乙酰氨基酚与漱口水生产商Kenvue的拟议收购，可能会把价值冲进下水道。
您已阅读9%（358字），剩余91%（3626字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。